Tumor biomarkers for diagnosis, prognosis and targeted therapy.
Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, Tian X, Guan X, Cen X, Zhao Y.
Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2.
'Acute myeloid leukemia: a comprehensive review and 2016 update'.
De Kouchkovsky I, Abdul-Hay M.
Blood Cancer J. 2016 Jul 1;6(7):e441. doi: 10.1038/bcj.2016.50.
Updates on targeted therapies for acute myeloid leukaemia.
Kayser S, Levis MJ.
Br J Haematol. 2022 Jan;196(2):316-328. doi: 10.1111/bjh.17746. Epub 2021 Aug 4.
Overview and recent advances in the treatment of neuroblastoma.
Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE.
Expert Rev Anticancer Ther. 2017 Apr;17(4):369-386. doi: 10.1080/14737140.2017.1285230. Epub 2017 Mar 15.
Treatment of Pediatric Low-Grade Gliomas.
Sait SF, Giantini-Larsen AM, Tringale KR, Souweidane MM, Karajannis MA.
Curr Neurol Neurosci Rep. 2023 Apr;23(4):185-199. doi: 10.1007/s11910-023-01257-3. Epub 2023 Mar 7.
Management of Gastrointestinal Stromal Tumors.
Keung EZ, Raut CP.
Surg Clin North Am. 2017 Apr;97(2):437-452. doi: 10.1016/j.suc.2016.12.001.
Small molecules, big impact: 20 years of targeted therapy in oncology.
Bedard PL, Hyman DM, Davids MS, Siu LL.
Lancet. 2020 Mar 28;395(10229):1078-1088. doi: 10.1016/S0140-6736(20)30164-1.
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.
Grimwade D, Ivey A, Huntly BJ.
Blood. 2016 Jan 7;127(1):29-41. doi: 10.1182/blood-2015-07-604496. Epub 2015 Dec 10.
Liver cancer stem cell markers: Progression and therapeutic implications.
Sun JH, Luo Q, Liu LL, Song GB.
World J Gastroenterol. 2016 Apr 7;22(13):3547-57. doi: 10.3748/wjg.v22.i13.3547.
Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel?
Bai X, Ni J, Beretov J, Graham P, Li Y.
Cancer Lett. 2021 Jan 28;497:100-111. doi: 10.1016/j.canlet.2020.10.016. Epub 2020 Oct 16.
